Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078561636> ?p ?o ?g. }
- W2078561636 endingPage "151" @default.
- W2078561636 startingPage "140" @default.
- W2078561636 abstract "To compare efficacy and safety of a tigecycline regimen with an imipenem/cilastatin regimen in hospital-acquired pneumonia patients, a phase 3, multicenter, randomized, double-blind, study evaluated 945 patients. Coprimary end points were clinical response in clinically evaluable (CE) and clinical modified intent-to-treat (c-mITT) populations at test-of-cure. Cure rates were 67.9% for tigecycline and 78.2% for imipenem (CE patients) and 62.7% and 67.6% (c-mITT patients), respectively. A statistical interaction occurred between ventilator-associated pneumonia (VAP) and non-VAP subgroups, with significantly lower cure rates in tigecycline VAP patients compared to imipenem; in non-VAP patients, tigecycline was noninferior to imipenem. Overall mortality did not differ between the tigecycline (14.1%) and imipenem regimens (12.2%), although more deaths occurred in VAP patients treated with tigecycline than imipenem. Overall, the tigecycline regimen was noninferior to the imipenem/cilastatin regimen for the c-mITT but not the CE population; this difference appears to have been driven by results in VAP patients." @default.
- W2078561636 created "2016-06-24" @default.
- W2078561636 creator A5006281776 @default.
- W2078561636 creator A5013463841 @default.
- W2078561636 creator A5018832115 @default.
- W2078561636 creator A5026090111 @default.
- W2078561636 creator A5030356447 @default.
- W2078561636 creator A5050194925 @default.
- W2078561636 creator A5052506517 @default.
- W2078561636 creator A5052948853 @default.
- W2078561636 creator A5067682787 @default.
- W2078561636 creator A5072249558 @default.
- W2078561636 creator A5074837538 @default.
- W2078561636 creator A5076488806 @default.
- W2078561636 creator A5077335209 @default.
- W2078561636 date "2010-10-01" @default.
- W2078561636 modified "2023-10-07" @default.
- W2078561636 title "Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia" @default.
- W2078561636 cites W1563232489 @default.
- W2078561636 cites W1965979675 @default.
- W2078561636 cites W1976790620 @default.
- W2078561636 cites W1998455639 @default.
- W2078561636 cites W1999156712 @default.
- W2078561636 cites W2004449157 @default.
- W2078561636 cites W2017363918 @default.
- W2078561636 cites W2024631123 @default.
- W2078561636 cites W2034482054 @default.
- W2078561636 cites W2034991857 @default.
- W2078561636 cites W2040587302 @default.
- W2078561636 cites W2041355416 @default.
- W2078561636 cites W2054740361 @default.
- W2078561636 cites W2078215757 @default.
- W2078561636 cites W2090169453 @default.
- W2078561636 cites W2090867698 @default.
- W2078561636 cites W2099249152 @default.
- W2078561636 cites W2101696246 @default.
- W2078561636 cites W2104051878 @default.
- W2078561636 cites W2105238960 @default.
- W2078561636 cites W2106784206 @default.
- W2078561636 cites W2109350493 @default.
- W2078561636 cites W2110992644 @default.
- W2078561636 cites W2135458987 @default.
- W2078561636 cites W2137408524 @default.
- W2078561636 cites W2139711757 @default.
- W2078561636 cites W2147441308 @default.
- W2078561636 cites W2152567832 @default.
- W2078561636 cites W2157622488 @default.
- W2078561636 cites W2161572091 @default.
- W2078561636 cites W2162258048 @default.
- W2078561636 cites W2168073283 @default.
- W2078561636 cites W2168849436 @default.
- W2078561636 cites W4211194064 @default.
- W2078561636 doi "https://doi.org/10.1016/j.diagmicrobio.2010.05.012" @default.
- W2078561636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20846586" @default.
- W2078561636 hasPublicationYear "2010" @default.
- W2078561636 type Work @default.
- W2078561636 sameAs 2078561636 @default.
- W2078561636 citedByCount "246" @default.
- W2078561636 countsByYear W20785616362012 @default.
- W2078561636 countsByYear W20785616362013 @default.
- W2078561636 countsByYear W20785616362014 @default.
- W2078561636 countsByYear W20785616362015 @default.
- W2078561636 countsByYear W20785616362016 @default.
- W2078561636 countsByYear W20785616362017 @default.
- W2078561636 countsByYear W20785616362018 @default.
- W2078561636 countsByYear W20785616362019 @default.
- W2078561636 countsByYear W20785616362020 @default.
- W2078561636 countsByYear W20785616362021 @default.
- W2078561636 countsByYear W20785616362022 @default.
- W2078561636 countsByYear W20785616362023 @default.
- W2078561636 crossrefType "journal-article" @default.
- W2078561636 hasAuthorship W2078561636A5006281776 @default.
- W2078561636 hasAuthorship W2078561636A5013463841 @default.
- W2078561636 hasAuthorship W2078561636A5018832115 @default.
- W2078561636 hasAuthorship W2078561636A5026090111 @default.
- W2078561636 hasAuthorship W2078561636A5030356447 @default.
- W2078561636 hasAuthorship W2078561636A5050194925 @default.
- W2078561636 hasAuthorship W2078561636A5052506517 @default.
- W2078561636 hasAuthorship W2078561636A5052948853 @default.
- W2078561636 hasAuthorship W2078561636A5067682787 @default.
- W2078561636 hasAuthorship W2078561636A5072249558 @default.
- W2078561636 hasAuthorship W2078561636A5074837538 @default.
- W2078561636 hasAuthorship W2078561636A5076488806 @default.
- W2078561636 hasAuthorship W2078561636A5077335209 @default.
- W2078561636 hasConcept C126322002 @default.
- W2078561636 hasConcept C2777027569 @default.
- W2078561636 hasConcept C2777437143 @default.
- W2078561636 hasConcept C2777914695 @default.
- W2078561636 hasConcept C2779631663 @default.
- W2078561636 hasConcept C2781255259 @default.
- W2078561636 hasConcept C2781413609 @default.
- W2078561636 hasConcept C2908647359 @default.
- W2078561636 hasConcept C501593827 @default.
- W2078561636 hasConcept C71924100 @default.
- W2078561636 hasConcept C86803240 @default.
- W2078561636 hasConcept C89423630 @default.
- W2078561636 hasConcept C94665300 @default.
- W2078561636 hasConcept C99454951 @default.